Related Experiment Video
Updated: Aug 8, 2025

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Immunity to fungi in the lung
Lena J Heung1, Darin L Wiesner2, Keyi Wang2
1Division of Infectious Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Abstract:
The respiratory tree maintains sterilizing immunity against human fungal pathogens. Humans inhale ubiquitous filamentous molds and geographically restricted dimorphic fungal pathogens that form small airborne conidia. In addition, pathogenic yeasts, exemplified by encapsulated Cryptococcus species, and Pneumocystis pose significant fungal threats to the lung. Classically, fungal pneumonia occurs in immune compromised individuals, specifically in patients with HIV/AIDS, in patients with hematologic malignancies, in organ transplant recipients, and in patients treated with corticosteroids and targeted biologics that impair fungal immune surveillance in the lung. The emergence of fungal co-infections during severe influenza and COVID-19 underscores the impairment of fungus-specific host defense pathways in the lung by respiratory viruses and by medical therapies to treat viral infections. Beyond life-threatening invasive syndromes, fungal antigen exposure can exacerbate allergenic disease in the lung. In this review, we discuss emerging principles of lung-specific antifungal immunity, integrate the contributions and cooperation of lung epithelial, innate immune, and adaptive immune cells to mucosal barrier immunity, and highlight the pathogenesis of fungal-associated allergenic disease. Improved understanding of fungus-specific immunity in the respiratory tree has paved the way to develop improved diagnostic, pre-emptive, therapeutic, and vaccine approaches for fungal diseases of the lung.
Insights
The respiratory system defends against fungal pathogens, but immune compromise or viral infections can lead to serious lung fungal diseases and allergies. Understanding lung antifungal immunity is key to developing better diagnostics and treatments.
Area of Science:
- Immunology
- Pulmonology
- Mycology
Background:
- The respiratory tract is constantly exposed to airborne fungal pathogens, including molds, yeasts, and dimorphic fungi.
- Fungal pneumonia classically affects immunocompromised individuals (e.g., HIV/AIDS, transplant recipients) and is exacerbated by viral infections like influenza and COVID-19.
- Fungal exposure can also trigger or worsen allergic lung diseases.
Purpose of the Study:
- To review emerging principles of lung-specific antifungal immunity.
- To integrate the roles of lung epithelial cells, innate immune cells, and adaptive immune cells in mucosal barrier immunity against fungi.
- To highlight the pathogenesis of fungal-associated allergic lung diseases.
Main Methods:
- This is a review article, synthesizing existing research on lung antifungal immunity.
- It integrates findings on cellular and molecular mechanisms of host defense against fungal pathogens.
- The review also examines the immunopathogenesis of fungal allergies in the respiratory tract.
Main Results:
- Lung epithelial cells and diverse immune cells (innate and adaptive) cooperate to maintain antifungal immunity.
- Respiratory viral infections and their treatments can impair these fungus-specific host defense pathways.
- Fungal antigens contribute to the development and exacerbation of allergic lung conditions.
Conclusions:
- Enhanced understanding of lung antifungal immunity provides a foundation for improved diagnostics, preemptive strategies, therapies, and vaccines for pulmonary fungal diseases.
- Targeting lung-specific immune responses holds promise for managing both invasive fungal infections and fungal allergies.
- Further research into the complex interplay between host immunity and fungal pathogens in the lung is warranted.
More Related Videos
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
09:52Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Related Concept Videos
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...